GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: D5v8 | Herceptin® | R-597
trastuzumab is an approved drug (FDA (1998), EMA (2000))
Compound class:
Antibody
Comment: Trastuzumab is a humanized IgG1κ monoclonal antibody targeting HER2.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Biosimilars:
View more information in the IUPHAR Pharmacology Education Project: trastuzumab |
Classification ![]() |
|
| Compound class | Antibody |
| Approved drug? | Yes. US FDA (1998) | EU EMA (2000) |
| WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 7637 | trastuzumab |
Synonyms ![]() |
| D5v8 | Herceptin® | R-597 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 97 |
Reactome Drug
|
R-ALL-9634466 |
Reactome Reaction
|
R-HSA-9665405, R-HSA-9649393, R-HSA-9652277, R-HSA-9665232, R-HSA-9665696 |
| Other databases | |
| GtoPdb PubChem SID | 178101775 |
| PubChem SID | 178101775 |
| Search PubMed clinical trials | trastuzumab |
| Search PubMed titles | trastuzumab |
| Search PubMed titles/abstracts | trastuzumab |
| Wikipedia | Trastuzumab |